IDO1/TDO dual inhibitor RY103 blocks the kynurenine pathway in pancreatic cancer, inhibiting cell motility and demonstrating growth inhibition in vivo [100]. The gene discussed is IDO1; the disease is familial pancreatic carcinoma.